Asia Pacific Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Androgenetic Alopecia Market would witness market growth of 9.0% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $364.8 Million by 2030. The Japan market is showcasing a CAGR of 8.3% during (2023 - 2030). Additionally, The India market would register a CAGR of 9.7% during (2023 - 2030).

With the availability of information online, consumers are more empowered to research and make informed decisions about their healthcare. The democratization of information enables individuals to explore various options, understand potential risks and benefits, and actively participate in discussions with healthcare providers. This sense of empowerment has led to a proactive approach in seeking and adopting androgenetic alopecia interventions. The adoption of surgical interventions, particularly hair transplantation techniques like Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE), is on the rise. These procedures involve the transplantation of healthy hair follicles from one part of the scalp to the balding areas, providing a permanent solution to androgenetic alopecia.

These are among the most widely adopted pharmaceutical products for androgenetic alopecia. Minoxidil, available as a topical solution, stimulates hair growth, while finasteride, an oral medication, inhibits the effects of the hormone dihydrotestosterone (DHT), a major contributor to hair loss in androgenetic alopecia. Low-level laser therapy (LLLT) devices, such as laser caps and helmets, are gaining adoption for their non-invasive approach to stimulating hair follicles and promoting hair growth. Platelet-rich plasma (PRP) injections involve using the patient's plasma to stimulate hair follicles. This non-surgical option has seen increased adoption for its minimal invasiveness.

The Asia Pacific pharmaceutical industry may witness the introduction of new pharmaceuticals designed to treat androgenetic alopecia. The Asia Pacific region is experiencing a demographic shift with a rising aging population. It is often contribute with aging, and the growing number of elderly individuals contributes to an increased prevalence of hair loss, driving the demand for pharmaceutical interventions in Asia Pacific. Urbanization and changes in lifestyle patterns in the Asia Pacific region contribute to increased stress and lifestyle-related factors, known as contributors to hair loss in Asia Pacific. There is a heightened awareness of androgenetic alopecia and available pharmaceutical solutions in the Asia Pacific region. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Cipla Limited
Merck & Co., Inc.
GlaxoSmithKline PLC (GSK)
Sun Pharmaceuticals Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma Limited
Pfizer, Inc.
Lutronic Co., Ltd.
Viatris Inc.
Eli Lilly and Company

Asia Pacific Androgenetic Alopecia Market Report Segmentation

By Treatment

Pharmaceuticals
Devices

By Gender

Male
Female

By Sales Channel

Prescriptions
OTC

By End-use

Dermatology Clinics
Homecare Settings

By Country

China
Japan
India
South Korea
Australia
Malaysia
Rest of Asia Pacific

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Asia Pacific Androgenetic Alopecia Market, by Treatment
- 1.4.2Asia Pacific Androgenetic Alopecia Market, by Gender
- 1.4.3Asia Pacific Androgenetic Alopecia Market, by Sales Channel
- 1.4.4Asia Pacific Androgenetic Alopecia Market, by End-use
- 1.4.5Asia Pacific Androgenetic Alopecia Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Asia Pacific Androgenetic Alopecia Market, By Treatment

4.1Asia Pacific Pharmaceuticals Market, By Country
4.2Asia Pacific Devices Market, By Country

Chapter 5.Asia Pacific Androgenetic Alopecia Market, By Gender

5.1Asia Pacific Male Market, By Country
5.2Asia Pacific Female Market, By Country

Chapter 6.Asia Pacific Androgenetic Alopecia Market, By Sales Channel

6.1Asia Pacific Prescriptions Market, By Country
6.2Asia Pacific OTC Market, By Country

Chapter 7.Asia Pacific Androgenetic Alopecia Market, By End-use

7.1Asia Pacific Dermatology Clinics Market, By Country
7.2Asia Pacific Homecare Settings Market, By Country

Chapter 8.Asia Pacific Androgenetic Alopecia Market, By Country

8.1China Androgenetic Alopecia Market
- 8.1.1China Androgenetic Alopecia Market, By Treatment
- 8.1.2China Androgenetic Alopecia Market, By Gender
- 8.1.3China Androgenetic Alopecia Market, By Sales Channel
- 8.1.4China Androgenetic Alopecia Market, By End-use
8.2Japan Androgenetic Alopecia Market
- 8.2.1Japan Androgenetic Alopecia Market, By Treatment
- 8.2.2Japan Androgenetic Alopecia Market, By Gender
- 8.2.3Japan Androgenetic Alopecia Market, By Sales Channel
- 8.2.4Japan Androgenetic Alopecia Market, By End-use
8.3India Androgenetic Alopecia Market
- 8.3.1India Androgenetic Alopecia Market, By Treatment
- 8.3.2India Androgenetic Alopecia Market, By Gender
- 8.3.3India Androgenetic Alopecia Market, By Sales Channel
- 8.3.4India Androgenetic Alopecia Market, By End-use
8.4South Korea Androgenetic Alopecia Market
- 8.4.1South Korea Androgenetic Alopecia Market, By Treatment
- 8.4.2South Korea Androgenetic Alopecia Market, By Gender
- 8.4.3South Korea Androgenetic Alopecia Market, By Sales Channel
- 8.4.4South Korea Androgenetic Alopecia Market, By End-use
8.5Australia Androgenetic Alopecia Market
- 8.5.1Australia Androgenetic Alopecia Market, By Treatment
- 8.5.2Australia Androgenetic Alopecia Market, By Gender
- 8.5.3Australia Androgenetic Alopecia Market, By Sales Channel
- 8.5.4Australia Androgenetic Alopecia Market, By End-use
8.6Malaysia Androgenetic Alopecia Market
- 8.6.1Malaysia Androgenetic Alopecia Market, By Treatment
- 8.6.2Malaysia Androgenetic Alopecia Market, By Gender
- 8.6.3Malaysia Androgenetic Alopecia Market, By Sales Channel
- 8.6.4Malaysia Androgenetic Alopecia Market, By End-use
8.7Rest of Asia Pacific Androgenetic Alopecia Market
- 8.7.1Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment
- 8.7.2Rest of Asia Pacific Androgenetic Alopecia Market, By Gender
- 8.7.3Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel
- 8.7.4Rest of Asia Pacific Androgenetic Alopecia Market, By End-use

Chapter 9.Company Profiles

9.1Cipla Limited
- 9.1.1Company Overview
- 9.1.2Financial Analysis
- 9.1.3Segmental and Regional Analysis
- 9.1.4Research & Development Expense
- 9.1.5SWOT Analysis
9.2Merck & Co., Inc.
- 9.2.1Company Overview
- 9.2.2Financial Analysis
- 9.2.3Segmental and Regional Analysis
- 9.2.4Research & Development Expenses
- 9.2.5SWOT Analysis
9.3GlaxoSmithKline PLC (GSK)
- 9.3.1Company Overview
- 9.3.2Financial Analysis
- 9.3.3Regional Analysis
- 9.3.4Research & Development Expense
- 9.3.5SWOT Analysis
9.4Sun Pharmaceuticals Industries Ltd.
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
9.5Dr. Reddy's Laboratories Ltd.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Segmental and Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5Recent strategies and developments:
  - 9.5.5.1Product Launches and Product Expansions:
- 9.5.6SWOT Analysis
9.6Aurobindo Pharma Limited
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
9.7Pfizer, Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Regional & Segmental Analysis
- 9.7.4Research & Development Expense
- 9.7.5Recent strategies and developments:
  - 9.7.5.1Trails and Approvals:
- 9.7.6SWOT Analysis
9.8Lutronic Co., Ltd.
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Regional Analysis
- 9.8.4Research & Development Expenses
- 9.8.5SWOT Analysis
9.9Viatris, Inc.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
9.10.Eli Lilly And Company
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4Research & Development Expenses
- 9.10.5SWOT Analysis

LIST OF TABLES

TABLE 1Asia Pacific Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 2Asia Pacific Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 3Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 4Asia Pacific Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 5Asia Pacific Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
TABLE 6Asia Pacific Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
TABLE 7Asia Pacific Devices Market, By Country, 2019 - 2022, USD Million
TABLE 8Asia Pacific Devices Market, By Country, 2023 - 2030, USD Million
TABLE 9Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 10Asia Pacific Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 11Asia Pacific Male Market, By Country, 2019 - 2022, USD Million
TABLE 12Asia Pacific Male Market, By Country, 2023 - 2030, USD Million
TABLE 13Asia Pacific Female Market, By Country, 2019 - 2022, USD Million
TABLE 14Asia Pacific Female Market, By Country, 2023 - 2030, USD Million
TABLE 15Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 16Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 17Asia Pacific Prescriptions Market, By Country, 2019 - 2022, USD Million
TABLE 18Asia Pacific Prescriptions Market, By Country, 2023 - 2030, USD Million
TABLE 19Asia Pacific OTC Market, By Country, 2019 - 2022, USD Million
TABLE 20Asia Pacific OTC Market, By Country, 2023 - 2030, USD Million
TABLE 21Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 22Asia Pacific Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 23Asia Pacific Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
TABLE 24Asia Pacific Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
TABLE 25Asia Pacific Homecare Settings Market, By Country, 2019 - 2022, USD Million
TABLE 26Asia Pacific Homecare Settings Market, By Country, 2023 - 2030, USD Million
TABLE 27Asia Pacific Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
TABLE 28Asia Pacific Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
TABLE 29China Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 30China Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 31China Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 32China Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 33China Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 34China Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 35China Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 36China Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 37China Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 38China Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 39Japan Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 40Japan Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 41Japan Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 42Japan Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 43Japan Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 44Japan Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 45Japan Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 46Japan Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 47Japan Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 48Japan Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 49India Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 50India Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 51India Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 52India Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 53India Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 54India Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 55India Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 56India Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 57India Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 58India Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 59South Korea Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 60South Korea Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 61South Korea Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 62South Korea Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 63South Korea Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 64South Korea Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 65South Korea Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 66South Korea Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 67South Korea Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 68South Korea Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 69Australia Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 70Australia Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 71Australia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 72Australia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 73Australia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 74Australia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 75Australia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 76Australia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 77Australia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 78Australia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 79Malaysia Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 80Malaysia Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 81Malaysia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 82Malaysia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 83Malaysia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 84Malaysia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 85Malaysia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 86Malaysia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 87Malaysia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 88Malaysia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 89Rest of Asia Pacific Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 90Rest of Asia Pacific Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 91Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 92Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 93Rest of Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 94Rest of Asia Pacific Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 95Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 96Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 97Rest of Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 98Rest of Asia Pacific Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 99Key Information - Cipla Limited
TABLE 100Key Information - Merck & Co., Inc.
TABLE 101Key Information - GlaxoSmithKline PLC
TABLE 102Key Information - Sun Pharmaceuticals Industries Ltd.
TABLE 103Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 104key information - Aurobindo Pharma Limited
TABLE 105Key Information - Pfizer, Inc.
TABLE 106Key Information - lUTRONIC cO., lTD.
TABLE 107key information - Viatris, Inc.
TABLE 108Key Information - Eli Lilly And Company

Asia Pacific Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents